EPITRACKER INC has a total of 19 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals and foods and drinks are RECEPTOR LIFE SCIENCES INC, BLAUGRUND ERAN and RESVERATROL PARTNERS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Venn-Watson Stephanie | 18 |
#2 | Reiner John | 6 |
#3 | Lumpkin Richard | 6 |
#4 | Venn Watson Stephanie | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020180814A1 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain | |
WO2020154173A1 | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity | |
WO2020146263A1 | Compositions and methods for diagnosis and treatment of neurodegenerative diseases | |
AU2019274431A1 | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity | |
CA3099561A1 | Compositions and methods for diagnosis and treatment of conditions related to aging | |
EP3661600A1 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |